Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 515.00
Bid: 514.00
Ask: 516.00
Change: 3.00 (0.59%)
Spread: 2.00 (0.389%)
Open: 515.00
High: 515.00
Low: 515.00
Prev. Close: 512.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisitions of VinciWorks Legal & Hydro-X Group

4 Oct 2021 07:00

RNS Number : 8231N
Marlowe PLC
04 October 2021
 

4 October 2021

 

Marlowe plc

 

Acquisitions of VinciWorks Legal Ltd and Hydro-X Group Ltd

 

Marlowe plc ("Marlowe" or the "Group"), the UK leader in business-critical services and software which assure safety and regulatory compliance, announces two acquisitions across its Governance Risk & Compliance (GRC) and Testing, Inspection & Certification (TIC) divisions for a combined consideration of up to £84 million.

Consistent with its clearly defined strategy focused on regulated compliance service and software sectors, Marlowe is significantly advancing its Digital offering by acquiring Vinci Legal Ltd ("VinciWorks"), the UK's leading regulatory compliance eLearning and software solution, whilst progressing its Deepen strategy by acquiring Hydro-X Group Ltd (together with its subsidiaries, "Hydro-X"), a leading water treatment and air hygiene business.

The acquisitions of VinciWorks and Hydro-X broaden Marlowe's end-to-end compliance software offering within GRC and deepen Marlowe's leading presence within existing TIC markets. Following the completion of both acquisitions, Group run-rate revenues are expected to be approximately £325 million and run-rate adjusted EBITDA is expected to be approximately £57 million. The consideration for both acquisitions is to be funded from cash and debt resources.

VinciWorks

Marlowe has acquired eLearning and compliance software VinciWorks for an initial consideration of £39 million payable in cash on completion and a contingent consideration estimated to be in the region of £15 million.

Headquartered in the UK, VinciWorks provides compliance eLearning software as a service (SaaS) and compliance management software to clients across a broad range of sectors. It has a strong market share in the legal, professional services and larger corporate sectors. VinciWorks further expands Marlowe's SaaS subscription revenue and offers cross-selling opportunities with the Group's GRC division's existing eLearning and compliance software business lines.

VinciWorks' subscription-based eLearning courses enable clients to implement compliance and ESG training across areas such as GDPR, anti-bribery, anti-money laundering, cyber-security, tax evasion, modern slavery, code of conduct and health & safety. Its Omnitrack software is a fully integrated SaaS compliance and risk management product which complements compliance eLearning by enabling clients to collect, analyse and report data across a broad range of enterprise-wide compliance issues.

Founded in 2003, VinciWorks has 31 employees and operations in both the UK and Israel, with 95% of revenues derived from the UK. With more than 95% of its revenue being generated from SaaS subscriptions, VinciWorks serves c.530 clients, including 60 of the UK's top 100 law firms and its platform is used by its clients across their locations in 30 different countries.

On a run-rate basis, the business generates £5.5 million of revenue and an adjusted EBITDA of £3.2 million, representing a 58% adjusted EBITDA margin. In the year to 31 August 2021, the business generated £5.3 million of revenue and an adjusted EBITDA of £2.7 million. As at 31 August 2021, VinciWorks had net assets of £1.4 million. The estimated contingent consideration payable in connection with the acquisition of VinciWorks of c.£15 million is based on VinciWorks achieving FY23 EBITDA of £5.1 million.

Hydro-X

Marlowe has exchanged contracts to acquire Hydro-X for a cash consideration of £30 million, payable on completion. The acquisition of Hydro-X is expected to complete by 21 October 2021.

Founded in 1984, Hydro-X is based in Sheffield and employs approximately 180 staff. The business is well-positioned in structural growth markets, providing a broad range of technical compliance services focused on water & air compliance, water treatment, fire safety and health & safety. The business is complementary to, and provides a number of attractive synergies with, Marlowe's TIC division. These synergies include cross-selling opportunities as well as a number of scale efficiencies, such as enhanced operational route density and the benefits from using Marlowe's existing sales, operational and back-office platforms.

In the year to 31 August 2021, Hydro-X generated revenue of £17.6 million and an adjusted EBITDA of £3.5 million, representing a 20% EBITDA margin. Hydro-X net assets as at 31 August 2021 were £5.3 million.

Alex Dacre, Chief Executive of Marlowe plc, said:

"Together, the acquisitions of VinciWorks and Hydro-X form a major step in delivering on the strategy announced at our Capital Markets Day, deepening our market share in attractive regulated TIC markets and significantly developing our digital proposition. VinciWorks advances our goal of becoming the market leader in governance, risk and compliance software and cements our position as the UK's leading GRC compliance eLearning business, whilst Hydro-X majorly contributes to our safety and compliance services in our TIC division, offering significant synergies with WCS Group. Whether via software or services, Marlowe is committed to becoming the one-stop shop for customers' safety and regulatory compliance needs."

For further information:

 

Marlowe plc

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

George Lawson

Berenberg (Joint Broker)

Ben Wright

Mark Whitmore

Tel: +44 (0)20 3207 7800

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

About Marlowe plc

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAXEDESKFFEA
Date   Source Headline
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM
13th Sep 20237:00 amRNSAnnual General Meeting and Trading Update
4th Sep 20237:00 amRNSHolding(s) in Company
8th Aug 20237:00 amRNSExercise of Share Options and Total Voting Rights
7th Aug 20237:45 amRNSResponse to Speculation
4th Aug 20233:50 pmRNSHolding(s) in Company
3rd Aug 20235:25 pmRNSHolding(s) in Company
31st Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
26th Jul 20237:00 amRNSAcquisition of IMSM
18th Jul 202312:15 pmRNSCapital Reduction Effective
13th Jul 20232:00 pmRNSPublication of Notice of AGM and Annual Report
29th Jun 20237:00 amRNSPreliminary results
26th Jun 20237:00 amRNSNotice of Full Year Results
23rd Jun 20234:56 pmRNSHolding(s) in Company
19th Jun 202311:06 amRNSResult of General Meeting
5th Jun 20239:31 amRNSHolding(s) in Company
2nd Jun 20232:51 pmRNSPosting of Circular and Notice of General Meeting
2nd Jun 202312:36 pmRNSHolding(s) in Company
18th Apr 20231:45 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSCapital Markets Day Replay
28th Mar 20237:00 amRNSCapital Markets Day and Trading Update
7th Mar 20237:00 amRNSNotice of Capital Markets Event
28th Feb 20232:20 pmRNSHolding(s) in Company
26th Jan 20231:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSNotice of Capital Markets Event
2nd Dec 20229:00 amRNSNotice of Investor Presentation
1st Dec 202210:34 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSDirector/PDMR Shareholding
24th Nov 20222:14 pmRNSDirector/PDMR Shareholding
24th Nov 20221:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSHalf-year Report
21st Nov 202212:54 pmRNSExercise of Share Options and Total Voting Rights
17th Nov 20227:00 amRNSNotice of Interim Results
2nd Nov 20225:08 pmRNSHolding(s) in Company
19th Oct 202210:40 amRNSExercise of Share Options and Total Voting Rights
14th Oct 20223:12 pmRNSHolding(s) in Company
11th Oct 20221:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.